Takeda Consumer Healthcare

History

2020: Blackstone Group купила Takeda Consumer Healthcare

At the end of August, 2020 the largest pharmaceutical company Takeda Pharmaceutical of Japan announced that it sells the business in the field of consumer health care to the American investment fund Blackstone Group. The fund intends to use resources of the Japanese company to develop drugs for rare or still incurable diseases.

In turn, Takeda sells the assets worldwide to reorient business and to reduce a debt after acquisition of Shire for $59 billion. The CEO of Takeda Christophe Weber announced at an online briefing that the company decided to sell the Japanese division on development of drugs of non-prescription dispensing because Takeda does not want to invest more means in this business and wishes to develop new drugs for therapy of more serious diseases.

Takeda sold Takeda Consumer Healthcare for $2.29 billion

My duty - to be convinced that we do not destroy, and we create new opportunities, and for this purpose we need to develop business. At the same time it is inexpedient to do business and not to make sufficient investments in it, - Weber told.

The Takeda Consumer Healthcare subsidiary company known for the line of the Alinamin energy drinks is estimated at 242 billion yens ($2.29 billion), but the selling price will be determined after calculation of its debt and other factors, Takeda claims. As reported Reuters agency in June, 2020, Blackstone was among finalists of biddings together with Bain Capital, CVC Capital Partners and Taisho Pharmaceutical Holdings Co Ltd. The Blackstone fund not for the first time buys new resources in Japan: in March, 2019 within the transaction for $1 billion the fund purchased producer of the anti-rheumatic medicines Ayumi Pharmaceutical Corp.

Takeda claims that sales proceeds will increase the net profit of the company by 105 billion yens. It is expected that the transaction with Blackstone will be closed till March 31, 2021 at observance of all conditions of regulatory bodies.^[1]

Notes